Balaxi Pharmaceuticals Limited

NSE:BALAXI.NS

86.04 (INR) • At close November 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

202320222021202020192018201720162015201420132012
Assets:
Current Assets:
Cash & Cash Equivalents 622.906282.16871.92916.6940.0071.3316.4623.0380.0010.0025.4685.309
Short Term Investments 2.8122,441.3891.8430000-0.0120.00100.1480.025
Cash and Short Term Investments 622.906282.16871.92916.6940.0071.3316.4623.0380.0020.0025.6165.334
Net Receivables 557.051550.73350.789784.305299.09456.436000.020.072.8860.347
Inventory 821.681,050.233987.036136.1798.321-56.436000-0.04900
Other Current Assets -2,001.63751.9780.2770.5331.19156.43616.8672.3420.0030.0031.7512.004
Total Current Assets 2,101.7181,935.1091,410.031937.707348.61357.76616.4625.380.0260.02610.2547.685
Non-Current Assets:
Property, Plant & Equipment, Net 147.783190.15552.02411.6861.8660.1140.0940.021000.0080.012
Goodwill 261.004252.235233.0212.7910000.358-0.009000
Intangible Assets 7.789.0958.2478.247000-0.3550.009000
Goodwill and Intangible Assets 261.004252.235241.26712.79100-16.8770.003-0-000
Long Term Investments -2,583.432-2,396.6944.69934.164000.0110.01532.5934.1331.7784.685
Tax Assets 2,583.4322,396.69-44.699-34.164359.70961.07816.8670.3580.004-000
Other Non-Current Assets 72.92719.19161.38434.625-350.477-57.880.312-0.012-32.263-33.7910-4.697
Total Non-Current Assets 481.714461.581354.67559.10211.0983.3120.4060.3850.3310.3421.7864.697
Total Assets 2,583.4322,396.691,764.706996.796359.71161.07816.86725.7660.3570.36812.0412.382
Liabilities & Equity:
Current Liabilities:
Account Payables 290.384364.803491.145220.57848.46720.8010.9440.00300.01300
Short Term Debt 176.61107.5136.38136.592000-0.0050.020.0251.8481.636
Tax Payables 050.56650.56624.62424.6244.7020.06900000
Deferred Revenue 28.83350.566088.4740001.8370-0.02500
Other Current Liabilities 46.1538.454105.151.28333.7515.0720.3770.3390.0220.0332.3953.225
Total Current Liabilities 541.98531.333632.676346.92782.21825.8731.3212.1740.0420.0464.2424.861
Non-Current Liabilities:
Long Term Debt 17.43225.55525.555443.813-82.2520000000
Deferred Revenue Non-Current -28.4567.892-25.555346.99882.25225.8731.3210.4560000
Deferred Tax Liabilities Non-Current 9.95411.0050.3880.0710.0340000.001000
Other Non-Current Liabilities 28.833-567.8930.001-790.811-0.001-25.873-1.321-0.4560.019000
Total Non-Current Liabilities 27.81936.5590.3890.0710.0330-15.14-00.02000
Total Liabilities 569.799567.892633.065346.99882.25125.8731.3212.1740.0420.0464.2424.861
Equity:
Preferred Stock 01,431.094918.651436.80764.4663.175000007.27
Common Stock 108.977101.81310010010030.430.430.40.3040.30477
Retained Earnings 2,013.6331,431.094918.65436.80764.4693.175-16.485-8.439-0.0050.0020.5460.27
Accumulated Other Comprehensive Income/Loss 2,013.633103.430.4610.4610.4610.46115.54623.2450.4610.250.250.25
Other Total Stockholders Equity -2,122.61-1,238.633-806.121-324.27748.064-2.0052.569-12.829-0.444-0.2340-14.54
Total Shareholders Equity 2,013.6331,828.7981,131.641649.798277.4635.20515.54623.5920.3150.3227.7967.52
Total Equity 1,567.3371,679.6951,096.093669.7237.45333.876-0.9140.2310.3150.3227.7967.52
Total Liabilities & Shareholders Equity 2,583.4322,396.691,764.706996.796359.71161.07816.86725.7660.3570.36812.03912.381